STAT+: Digital tools for diabetes management did not deliver benefits that justify cost, new report finds
STAT March 21, 2024
The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.
A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to...